Residential treatment programs are a common, costly setting for treating opioid use disorder1 and are frequently promoted in policy proposals to improve access to care.2 However, concerns have been raised about the quality of care and low use of evidence-based opioid agonist treatment (OAT) in these settings.3 Most data available on programs come from self-reported surveys4 that may not reflect patient experience, so we simulated patient calls to audit treatments offered by programs nationally.
Beetham T, Saloner B, Gaye M, Wakeman SE, Frank RG, Barnett ML. Therapies Offered at Residential Addiction Treatment Programs in the United States. JAMA. 2020;324(8):804–806. doi:10.1001/jama.2020.8969
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: